Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
The Biochemical Journal|June 19, 2003
Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloidJacqueline F Aitken, Kerry M Loomes, Barbara Konarkowska, et al.The FEBS Journal|August 4, 2006
The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cellsBarbara Konarkowska, Jacqueline F Aitken, Joerg Kistler, et al.The FEBS Journal|September 24, 2005
Thiol reducing compounds prevent human amylin-evoked cytotoxicityBarbara Konarkowska, Jacqueline F Aitken, Joerg Kistler, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 2009
Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3Samuel D Robinson, Jacqueline F Aitken, Richard J Bailey, et al.Nature Reviews. Endocrinology|May 13, 2025
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitusChristopher S Walker, Jacqueline F Aitken, Greeshma Vazhoor Amarsingh, et al.Peptides|April 25, 2019
Glucoregulatory activity of vesiculin in insulin sensitive and resistant miceKate L Lee, Jacqueline F Aitken, Huai-L Hsu, et al.The Biochemical Journal|August 26, 2010
The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type 2 diabetesVita Chien, Jacqueline F Aitken, Shaoping Zhang, et al.Journal of Functional Biomaterials|June 24, 2014
Monodisperse 130 kDa and 260 kDa Recombinant Human Hemoglobin Polymers as Scaffolds for Protein Engineering of Hemoglobin-Based Oxygen CarriersDavid A Marquardt, Michael P Doyle, Jeffrey S Davidson, et al.Islets|October 11, 2021
Vesiculin derived from IGF-II drives increased islet cell mass in a mouse model of pre-diabetesKate L Lee, Jacqueline F Aitken, Xun Li, et al.Diabetes|October 2, 2009
Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic miceJacqueline F Aitken, Kerry M Loomes, David W Scott, et al.Pageof 2